What Virtue does

Virtue is the earliest-stage dedicated healthcare venture capital firm, founded in 2024 and headquartered in Austin, Texas. The firm backs elite founders building AI-native companies that transform the healthcare ecosystem, deploying initial checks of $500K to $4M at the pre-seed and seed stages (the 0-to-1 phase of company building). Its portfolio of 25+ companies spans a deliberately diversified healthcare AI stack, including clinical documentation (Dart Health), healthcare financial planning and FP&A (Translucent), AI-native health insurance brokerage (Gyde), AI-powered dental claims administration (LightSpun), life sciences drug diligence (Prudentia Sciences), multimodal foundation models for biopharma (Standard Model Bio), value-based mental health care (Amae Health), autism care (Anna), senior home care payroll (Clara), clinical trial financial infrastructure (Mural Health), healthcare data compliance (Integral), and precision microbiome care (Evvy).

Virtue's core capability is deal sourcing and thesis-driven investing rather than technology development; the firm itself does not build proprietary AI models, platforms, or software. Its competitive positioning rests on (1) exclusive vertical focus on healthcare AI and life sciences, (2) operational domain expertise brought by its two named principals (Sean Doolan and Emre Karatas, both listed as Investors), and (3) co-investment validation from tier-1 healthcare and tech VCs including GV, NEA, Lightspeed, McKesson Ventures, Optum Ventures, SignalFire, and FPV Ventures across its portfolio rounds.

The business model is conventional venture capital: Virtue raises capital from limited partners, deploys it into portfolio companies in exchange for equity, and earns returns through exits (acquisitions or IPOs). No management fees, AUM, fund size, or realizations are disclosed in the source material. The firm's go-to-market is founder-network-driven direct investment, supplemented by a content-marketing layer of public investment thesis articles published on its website. Geographic focus is the United States, though portfolio companies such as Prudentia Sciences are already expanding into Asia-Pacific and Europe, signaling potential for cross-border deal flow in future funds.

Name

Virtue

Legal name

Virtue

Website

https://virtuevc.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Virtue is a 2024-founded Austin-based venture capital firm that deploys $500K–$4M pre-seed and seed checks into elite founders building AI-native healthcare and life sciences companies. Its 25+ company portfolio spans clinical, financial, insurance, and biopharma AI applications.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Healthcare venture capital
• Seed stage investing
• Healthcare AI startups
• Early-stage funding
• Pre-seed investments

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Venture Capital Returns: Virtue generates returns through equity investments in early-stage healthcare companies. The firm earns returns when portfolio companies achieve successful exits through acquisitions or IPOs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Virtue is a venture capital firm that invests in pre-seed and seed stage healthcare AI startups, typically deploying between $500K and $4M per company. The firm backs a portfolio of more than 25 healthcare AI companies and operates from Austin, United States.

Product overview

Virtue is a venture capital firm specializing in early-stage healthcare investments, typically deploying $500K to $4M in initial checks to back elite founders transforming the healthcare ecosystem. The firm does not offer a unified product platform; instead, it provides investment capital, strategic guidance, and operational support to early-stage healthcare companies. Its portfolio spans AI-powered healthcare solutions including clinical documentation, financial intelligence, data compliance, and healthcare administration tools.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-seed investment capital

Quantifiable outcome

• Portfolio company Translucent raised $34M total funding ($7M seed + $27M Series A) and serves hundreds of millions in revenue for customers.
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Flare Capital Partners: Healthcare-focused venture capital firm investing at seed and early stages in healthcare technology and services companies. Directly comparable to Virtue due to identical healthcare vertical focus and similar early-stage check size thesis.
• FPV Ventures: Seed and early-stage venture firm focused on transformative technology companies. Directly comparable as a micro-VC co-investor, having participated alongside Virtue in Translucent's Series A.
• SignalFire: Early-stage venture capital firm with a dedicated healthcare and AI practice, using proprietary data to source deals. Comparable as an early-stage investor that co-invested with Virtue in Prudentia Sciences.
• Brewer Lane Ventures: Early-stage venture firm investing in healthcare and technology companies, often leading seed and Series A rounds. Comparable as a co-investor with Virtue in LightSpun, with similar healthcare-oriented early-stage thesis.
• Lux Capital: Early-stage venture firm with deep healthcare, biotech, and frontier-tech specialization, often investing at the earliest stages. Comparable as an early-stage specialist with a strong healthcare thesis, though Lux operates at a larger fund scale and broader sector remit.

Broad incumbents

• Optum Ventures: The corporate venture arm of Optum/UnitedHealth Group, investing in healthcare AI and technology startups. Comparable as a healthcare-focused VC investor that co-invested with Virtue in Gyde, but operates at meaningfully larger scale.
• GV (Google Ventures): The venture investment arm of Alphabet, making sizable early- and growth-stage bets in healthcare AI and life sciences. Comparable as a co-investor with Virtue in Translucent and Prudentia Sciences, though operating at vastly larger fund scale.
• Lightspeed Venture Partners: Large multi-stage venture firm with deep healthcare and enterprise software coverage. Comparable as a co-investor with Virtue in Gyde's $60M launch, though at materially larger AUM and broader sector focus.
• McKesson Ventures: Healthcare-focused corporate venture arm of McKesson, investing in startups modernizing pharma, life sciences, and care delivery. Comparable as a healthcare vertical specialist that co-led Prudentia Sciences, but operating at much larger AUM.
• a16z Bio + Health: Andreessen Horowitz's dedicated bio/healthcare investment fund, investing across stages in healthcare AI, biotech, and digital health. Comparable as a high-profile healthcare AI investor, though operating at vastly larger AUM and broader stage range than Virtue.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/virtue_vc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments24 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtue